Why the study?
Does chlorothiazide lower arterial pressure through decreases in plasma volume in hypertensive patients?
Does chlorothiazide lower arterial pressure through decreases in plasma volume in hypertensive patients?
The short-term antihypertensive effects of chlorothiazide are driven by plasma volume reduction rather than a specific direct antihypertensive mechanism.
Short-term diuretic BP reduction is volume-mediated in hypertension; leaves open direct vascular effects with chronic use.
Enhanced responsiveness to ganglioplegic drugs occurring during short-term treatment with chlorothiazide has been attributed to increased vasomotor tone evoked by oligemia.¹Diuretic-induced oligemia also seems responsible for increased depressor responses to trimethapan (Arfonad) and decreased pressor responses to norepinephrine.²Chlorothiazide alone can lower arterial pressure in some hypertensive patients,¹⁻³and this effect may result from a decrease of plasma volume. This report describes the oligemic and antihypertensive effects of the diuretic in hypertensive patients receiving the drug for varying periods. The results support the suggestion¹that decreases of arterial pressure observed during short-term diuretic therapy result from decreases of plasma volume and not from a specific antihypertensive effect. Methods Studies were performed in 17 hypertensive patients hospitalized in the Research Ward of the Cleveland Clinic Hospital. Fifteen received a 100 mEq. sodium diet, and two—who had previously suffered from congestive cardiac failure—continued to take a 55
No takes yet. Share an insight, caveat, or question.
Cathel A. Macleod (1960) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: